Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies

International Journal of Cancer

Volumn 130, Issue 7, 2012, Pages 1639-1648

  Wang, Chenggang ^a   Wang, Xiaolin ^a   Gong, Gaoquan ^a   Ben, Qiwen ^b   Qiu, Weili ^a   Chen, Yi ^a   Li, Guoping ^a   Wang, Liangwen ^a  

^a FUDAN UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

diabetes mellitus; hepatocellular carcinoma; incidence; meta analysis; mortality; systematic review

Indexed keywords

ALCOHOL CONSUMPTION; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDICAL HISTORY; META ANALYSIS (TOPIC); PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ADULT; AGED; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS;

EID: 79961218135     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26165     Document Type: Review

References (47)

1. El-Serag HB, Mason AC,. Risk factors for the rising rates of primary liver cancer in the United States. Arch Int Med 2000; 160: 3227-30.
2. Yu MC, Yuan JM,. Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 2004; 127: S72-S8.
3. Bugianesi E,. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis 2007; 11: 191-207, x-xi. (Pubitemid 46829971)
4. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, Wang LY, Sun CA, Lu SN, Chen DS, Chen CJ,. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 2008; 135: 111-21.
5. Zimmet P, Alberti KG, Shaw J,. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-7. (Pubitemid 34000780)
6. Heidemann C, Boeing H, Pischon T, Nothlings U, Joost HG, Schulze MB,. Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol 2009; 24: 281-8.
7. Saltzman BS, Doherty JA, Hill DA, Beresford SA, Voigt LF, Chen C, Weiss NS,. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 2008; 167: 607-14. (Pubitemid 351323306)
8. Ben Q, Cai Q, Li Z, Yuan Y, Ning X, Deng S, Wang K,. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer 2011; 48: 248-54.
9. El-Serag HB, Hampel H, Javadi F,. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369-80. (Pubitemid 43343895)
10. Chen HF, Chen P, Li CY,. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology (Baltimore. Md.) 2010; 52: 155-63.
11. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S,. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Int Med 2006; 166: 1871-7. (Pubitemid 44455170)
12. Lai MS, Hsieh MS, Chiu YH, Chen TH,. Type 2 diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology (Baltimore. Md.) 2006; 43: 1295-302. (Pubitemid 43980108)
13. Torisu Y, Ikeda K, Kobayashi M, Hosaka T, Sezaki H, Akuta N, Kawamura Y, Yatsuji H, Suzuki F, Suzuki Y, Arase Y, Kumada H,. Diabetes mellitus increases the risk of hepatocarcinogenesis in patients with alcoholic cirrhosis: a preliminary report. Hepatol Res 2007; 37: 517-23. (Pubitemid 46864247)
14. Veldt BJ, Chen W, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, de Knegt RJ, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL,. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology (Baltimore. Md.) 2008; 47: 1856-62. (Pubitemid 351945553)
15. Ogunleye AA, Ogston SA, Morris AD, Evans JM,. A cohort study of the risk of cancer associated with type 2 diabetes. Br J Cancer 2009; 101: 1199-201.
16. Wang CS, Yao WJ, Chang TT, Wang ST, Chou P,. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses. Cancer Epidemiol Biomarkers Prev 2009; 18: 2054-60.
17. Jee SH, Ohrr H, Sull JW, Samet JM,. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004; 96: 1851-56. (Pubitemid 40081322)
18. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, Persson I,. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307-14.
19. Zendehdel K, Nyren O, Ostenson CG, Adami HO, Ekbom A, Ye W,. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 2003; 95: 1797-800. (Pubitemid 38008903)
20. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K,. Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med 2010; 27: 791-7.
21. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88. (Pubitemid 17189972)
22. Fujino Y, Mizoue T, Tokui N, Yoshimura T,. Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes/Metab Res Rev 2001; 17: 374-9. (Pubitemid 33040310)
23. Tazawa J, Maeda M, Nakagawa M, Ohbayashi H, Kusano F, Yamane M, Sakai Y, Suzuki K,. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Digest Dis Sci 2002; 47: 710-5. (Pubitemid 34286861)
24. Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003; 97: 3036-43. (Pubitemid 36676258)
25. Uetake S, Yamauchi M, Itoh S, Kawashima O, Takeda K, Ohata M,. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection. Alcoholism, clinical and experimental research 2003; 27: 47S-51S. (Pubitemid 36999200)
26. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ,. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159: 1160-7. (Pubitemid 38747263)
27. El-Serag HB, Tran T, Everhart JE,. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004; 126: 460-8. (Pubitemid 38182303)
28. N'Kontchou G, Paries J, Htar MT, Ganne-Carrie N, Costentin L, Grando-Lemaire V, Trinchet JC, Beaugrand M,. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol 2006; 4: 1062-8. (Pubitemid 44137435)
29. Ioannou GN, Splan MF, Weiss NS, McDonald GB, Beretta L, Lee SP,. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2007; 5: 938-45, 45 e1-45 e4.
30. Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, Yamashiki N, Yoshida H, Kanai F, Kato N, Shiina S, Yoshida H, et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol 2008; 6: 459-64. (Pubitemid 351443115)
31. Ikeda K, Kobayashi M, Someya T, Saitoh S, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Kumada H,. Occult hepatitis B virus infection increases hepatocellular carcinogenesis by eight times in patients with non-B, non-C liver cirrhosis: a cohort study. J Viral Hep 2009; 16: 437-43.
32. Khan M, Mori M, Fujino Y, Shibata A, Sakauchi F, Washio M, Tamakoshi A,. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort (JACC) Study. Asian Pac J Cancer Prev 2006; 7: 253-9.
33. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, Wolk A, McLaughlin JK, Fraumeni JF Jr,. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996; 88: 1472-7. (Pubitemid 26340049)
34. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, Borch-Johnsen K, Olsen JH,. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997; 89: 1360-5. (Pubitemid 27418027)
35. Kessler II,. Cancer mortality among diabetics. J Natl Cancer Inst 1970; 44: 673-86.
36. Verlato G, Zoppini G, Bonora E, Muggeo M,. Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 2003; 26: 1047-51. (Pubitemid 36929246)
37. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, Waugh NR, Morris AD, Gatling W, Gale EA, Patterson CC, Keen H,. Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 2005; 92: 2070-5. (Pubitemid 40897432)
38. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM,. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202. (Pubitemid 40095870)
39. Ragozzino M, Melton LJ III, Chu CP, Palumbo PJ,. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Diseases 1982; 35: 13-9. (Pubitemid 12213476)
40. Miyamoto H, Moriishi K, Moriya K, Murata S, Tanaka K, Suzuki T, Miyamura T, Koike K, Matsuura Y,. Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein. J Virol 2007; 81: 1727-35. (Pubitemid 46214447)
41. Masini M, Campani D, Boggi U, Menicagli M, Funel N, Pollera M, Lupi R, Del Guerra S, Bugliani M, Torri S, Del Prato S, Mosca F, et al. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care 2005; 28: 940-1. (Pubitemid 40434503)
42. Wiencke JK,. Impact of race/ethnicity on molecular pathways in human cancer. Nature Rev 2004; 4: 79-84. (Pubitemid 38082156)
43. Weng CJ, Hsieh YH, Tsai CM, Chu YH, Ueng KC, Liu YF, Yeh YH, Su SC, Chen YC, Chen MK, Yang SF,. Relationship of insulin-like growth factors system gene polymorphisms with the susceptibility and pathological development of hepatocellular carcinoma. Ann Surg Oncol 2010; 17: 1808-15.
44. Clark JM, Brancati FL, Diehl AM,. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98: 960-7. (Pubitemid 36733754)
45. Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C,. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology (Baltimore. Md.) 2004; 40: 820-6. (Pubitemid 39288114)
46. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P,. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005; 129: 113-21. (Pubitemid 41002048)
47. Papa S, Bubici C, Zazzeroni F, Franzoso G,. Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol Chem 2009; 390: 965-76.